<![CDATA[Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents (Volume 5 - Issue 6)]]> https://eurekaselect.com/journal/88 RSS Feed for Journals | BenthamScience EurekaSelect (+https://eurekaselect.com) 1970-01-01 <![CDATA[Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents (Volume 5 - Issue 6)]]> https://eurekaselect.com/journal/88 <![CDATA[ Editorial [Hot Topic: Recent Progress in the Development of Anti-Diabetic Drugs (Guest Editor: J. Eckel)]]]>https://eurekaselect.com/article/353241970-01-01 <![CDATA[ Clinical View on the Need to Develop New Anti-Diabetic Drugs]]>https://eurekaselect.com/article/353251970-01-01 <![CDATA[ Insulin Analogs Revisited]]>https://eurekaselect.com/article/353261970-01-01 <![CDATA[ GLP-1, Incretin Mimetics and DPP 4 Inhibitors: New Ways in the Treatment of Type 2 Diabetes]]>https://eurekaselect.com/article/353271970-01-01 <![CDATA[ The Mode of Action of the Antidiabetic Drug Glimepiride-Beyond Insulin Secretion]]>https://eurekaselect.com/article/353281970-01-01 <![CDATA[ Glucose Transport Regulators]]>https://eurekaselect.com/article/353291970-01-01 <![CDATA[ Serine Kinases as New Drug Targets for the Treatment of Type 2 Diabetes]]>https://eurekaselect.com/article/353301970-01-01 <![CDATA[ Editorial [ Hematopoietic Stem Cell Transplantation and Graft-Versus-Host Disease (Guest Editor: T. Iwasaki)]]]>https://eurekaselect.com/article/353311970-01-01 <![CDATA[ Graft Versus Host Disease]]>https://eurekaselect.com/article/353321970-01-01 <![CDATA[ A New Bone Marrow Transplantation Method for the Prevention of Graft- Versus-Host Disease]]>https://eurekaselect.com/article/353331970-01-01 <![CDATA[ In Vitro and In Vivo Sirolimus for Modulation of Allogeneic Hematopoietic Stem Cell Transplantation]]>https://eurekaselect.com/article/353341970-01-01 <![CDATA[ Protective Growth Factors for Graft-Versus-Host Disease]]>https://eurekaselect.com/article/353351970-01-01 <![CDATA[ The Parent-into-F1 Model of Graft-vs-Host Disease as a Model of In Vivo T Cell Function and Immunomodulation]]>https://eurekaselect.com/article/353361970-01-01 <![CDATA[ GVHD: Complication and Challenge to Successful Allogeneic Hematopoietic Cell Transplantation]]>https://eurekaselect.com/article/353371970-01-01